Overview
Dr. Susanna Naggie completed her undergraduate degrees in chemical engineering and biochemistry at the University of Maryland, College Park, and her medical education at Johns Hopkins School of Medicine. She conducted her internal medicine and infectious diseases fellowship training at Duke University Medical Center, where she also served as Chief Resident. She joined the faculty in the Duke School of Medicine in 2009. She is a Professor of Medicine and currently holds appointments at the Duke University School of Medicine, at the Duke Clinical Research Institute, and at the Durham Veterans Affairs Medical Center. Dr. Naggie is a clinical investigator with a focus in clinical trials in infectious diseases and translational research in HIV and liver disease. She is a standing member of the DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents and the CDC/NIH/IDSA-HIVMA Opportunistic Infections Guideline. She is the Vice Dean for Clinical and Translational Research and Director for the Duke Clinical and Translational Sciences Institute.
Current Appointments & Affiliations
In the News
View All News
Recent Publications
AASLD ISDA Practice Guideline on treatment of chronic hepatitis B.
Journal Article Hepatology · April 1, 2026 BACKGROUND AND AIMS: Accumulating data related to prevention, surveillance and treatment of chronic hepatitis B (CHB) provided the impetus for this updated guideline, using the Grading of Recommendation Assessment, Development and Evaluation (GRADE) approa ... Full text Link to item CiteMetformin Therapy for Patients With COVID-19 Without Obesity-Reply.
Journal Article JAMA Intern Med · March 1, 2026 Full text Link to item CiteShort Course Therapy With Glecaprevir/Pibrentasvir for Early Hepatitis C Virus Infection: PURGE-C.
Journal Article Clin Infect Dis · February 4, 2026 BACKGROUND: Shorter treatment courses for early hepatitis C virus (HCV) infection could simplify treatment approaches, particularly in key populations. METHODS: PURGE-C (A5380) was a single-arm, multicenter trial evaluating the treatment of early HCV (prim ... Full text Link to item CiteRecent Grants
1/3 CTSA UM1 at Duke University
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2025 - 2032Combating Related Epidemics in HCV through Simplified Testing and Treatment (CREST). A cluster randomized trial of point-of-care hepatitis C testing and treatment among key populations
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2025 - 2030Interdisciplinary Research Training Program in AIDS
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2010 - 2030View All Grants